We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

75,000-molecule Screen Reveals Amyloid-reducing Compound

News   Feb 20, 2019 | Original Press Release from Boston University School of Medicine

 
75,000-molecule Screen Reveals Amyloid-reducing Compound

In the Alzheimer’s affected brain, abnormal levels of the beta-amyloid protein clump together to form plaques (seen in brown) that collect between neurons and disrupt cell function. Abnormal collections of the tau protein accumulate and form tangles (seen in blue) within neurons, harming synaptic communication between nerve cells. Credit: National Institute on Aging, NIH via Flickr under CC BY-NC 2.0.

 
 
 

RELATED ARTICLES

Fruit Fly Gene Study Shows the Complexity of Neurodevelopmental Disorders

News

Researchers have evaluated the effects of genes implicated in neurodevelopmental disorders; the results suggest that the disorders have a complex causation involving many genes.

READ MORE

What Links Larger Brain Ventricles and Schizophrenia?

News

A new study suggests that two microRNAs play a critical role in a mechanism that results in ventricular enlargement in a type of mouse model.

READ MORE

A New Way To Measure Beta Brain Bursts

News

Neuroscientists have developed a new method for analyzing beta wave bursts, paving the way for investigating their role in particular behaviors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE